Mark Jason Heath Ellison - Jan 27, 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Development Officer
Signature
/s/ Mark Jason Heath Ellison
Stock symbol
OPNT
Transactions as of
Jan 27, 2023
Transactions value $
-$12,359
Form type
4
Date filed
1/31/2023, 03:21 PM
Previous filing
Jan 9, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$12.4K -610 -3.15% $20.26 18.8K Jan 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.